[2] Korner M, Stockli M, Waser B, et al. GLP-1 receptor expression in human tumors and humannormal tissues: potential for in vivo targeting[J].Nucl Med. 2007, 48(5): 736-743. [3] Meloni A R, Deooung M B, Loee C, et al. ...
[88] Schlatter, P., Beglinger, C., Drewe, J., Gutmann, H. 2007. Glucagon-like peptide 1receptor expression in primary porcine proximal tubular cells. Regul Pept 141:120-128. [89] Pacheco, B.P., Crajoinas, R.O., Couto, G.K., Davel, A.P., Lessa, L.M., Rossoni, L.V.,...
M., Asarian, L., Langhans, W., et al. 2010. Hepatic-portal vein infusions of glucagon-like peptide-1 reduce meal size and increase c-Fos expression in the nucleus tractus solitarii, area postrema and central nucleus of the amygdala in rats. J Neuroendocrinol 22:557-563. ...
[20] Schlatter, P. et al. Glucagon-like peptide 1 receptor expression in primary porcine proximal tubular cells. Regul Pept. 2007, 141, 120-128. 近期会议 REVIEW 苏州.第二届多肽药物产业创新论坛 (2023.4.15-16) 南京.第三届小...
Kvist PH. Glucagon-like peptide-1 receptor expression in the human eye. Diabetes Obes Metabol 2018;20:2304e8. END 文案| 刘卫勤 排版| 姜笑南 审核| 姜笑南 发布|姜笑南 世界生命科学大会 RECRUIT 关注我们,获取生命科学 学界前沿|促进更多的学术交流与合作 ...
Passage stability analysis of receptor expression by FACS. Flow cytometry surface staining of human GCGR on Human GCGR (Luc) HEK293 Reporter Cell (Cat. No.CHEK-ATF103) demonstrates consistent mean fluorescent intensity across passage 7-20.
了解GLP-1影响体重的相关机制。 自胰高糖素样肽-1(GLP-1)被发现以来,已然成为一种“多面手”激素——其接二连三的代谢功能被人们发现,远远超出了作为肠促胰素的经典定义。GLP-1众多有益的作用使其受体激动剂逐渐成为更多新兴的治疗领域如脂肪肝、肥胖和神经退行性疾病等的冉冉之“星”药物,而GLP-1的减重作用...
tumors and to compare it with that in nonneoplastic tissues.The GLP-1 receptor protein expression was qualitatively and quantitatively investigated in a broad spectrum of human tumors (n=419) and nonneoplastic human tissues (n=209) with receptor autoradiography using (125)I-GLP-1(7-36)amide. ...
[17] Li, Y., Cao, X., Li, L.X., Brubaker, P.L., Edlund, H., Drucker, D.J. 2005. beta-Cell Pdx1 expression is essential for the glucoregulatory, proliferative, and cytoprotective actions of glucagon-like peptide-1. Diabetes 54:482-491. ...
自胰高糖素样肽-1(GLP-1)被发现以来,它已然成为一种“多面手”激素——其多种代谢功能被人们发现,远远超出了作为肠促胰素的经典定义。GLP-1的众多有益的靶点作用使其受体激动剂逐渐成为更多新兴的治疗领域如脂肪肝、肥胖和神经退行性疾病等的冉冉之“星”药物。时值利拉鲁肽在我国上市10周年,司美格鲁肽新上市之...